<DOC>
	<DOCNO>NCT00420563</DOCNO>
	<brief_summary>The scope trial ass free progression rate 2 month group patient .</brief_summary>
	<brief_title>Metronomic Chemotherapy Cyclophosphamide Versus Megestrol Palliative Cancer</brief_title>
	<detailed_description />
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Age &gt; = 18 PSWHO &lt; = 1 Histologically proven cancer No therapeutic proposal Treatment orally take Radiologic proof evolutive character disease Effective contraception Hypercalcemia ( Ca &gt; 2.65 mmol/l ) Breast cancer Thrombosis pulmonary embolism Dysphagia , malabsorption Polynuclear neutrophil leukocytes &lt; 1000/mm3 Treatment Tegretol Active uncontrolled infection Evolutive psychiatric disease Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Cancer , palliative treatment</keyword>
</DOC>